Scientists at Scripps Research and the University of Utah published work showing that the retina can be revived up to 5 hours after a person has died.
This study, published in Nature, suggests that nerve cells from the central nervous system may be easier to revive after death than scientists had widely believed. (via)
In other news ... a bunch of B words.
Byooviz, the first FDA-approved ophthalmology biosimilar, launched in the United States. Read a previous rundown on Byooviz here.
Novartis announced that the FDA has approved Beovu for the treatment of diabetic macular edema. A previous rundown on Beovu can be found here.
See you next week!